Brian DeRubertis (Weill Cornell Medicine, New York, USA) explains why he is optimistic about advances being made in treatment for below-knee peripheral arterial disease (PAD), including efforts to find a drug-coated balloon (DCB)—be it paclitaxel or limus—that works in the segment.
Most read
Features
Profiles
